These endocrine disruptions led to an increase in circulating IGF-1, which can bind to the IGF receptor complex, and correspondingly activate pathways that stimulate cell proliferation and impair apoptosis, leading to tumor cell growth [58]. This evidence concerns the gene IGF1 and neoplasm.